Latest News
Arbutus Biopharma Corporation
- Arbutus Biopharma Corporation Estimates – NASDAQ:ABUS
- Why Is Arbutus Biopharma Stock Trading Higher Today? - Arbutus Biopharma (NASDAQ:ABUS)
- Arbutus Biopharma says FDA lifts AB-101 clinical hold
- Why is Arbutus Biopharma stock climbing today? By Investing.com
- Why is Arbutus Biopharma stock climbing today? By Investing.com
- FDA lifts clinical hold on Arbutus Biopharma's AB-101 drug candidate
- Form 8K Arbutus Biopharma Corp For: 22 October By Investing.com
- Arbutus Biopharma Clears FDA Clinical Hold on AB-101 IND
- Arbutus Biopharma rated Buy on $179M Moderna de...
- Arbutus Biopharma: $230M Buyback And Moderna Cash De-Risk The Path To A Potential HBV Cure
- Arbutus Biopharma Options Spot-On: On September 30th, 85,830 Contracts Were Traded, With 211.05K Open Interest
- Arbutus Biopharma (ABUS) Shares Rise on $230M Share Buyback Comp
Headlines from the last 30 days, linking to the original publishers. See all market news →